# Resveratrol Trial for Relief of Pain in Pseudoachondroplasia

> **NCT03866200** · PHASE2 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 6 (actual)

## Conditions studied

- Pseudoachondroplasia

## Interventions

- **DRUG:** resveratrol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03866200
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-29
- **Primary completion:** 2020-10-28
- **Final completion:** 2020-10-28
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Inability to recruit target number
- **Last updated:** 2022-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03866200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03866200, "Resveratrol Trial for Relief of Pain in Pseudoachondroplasia". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03866200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*